India Pharma Outlook Team | Friday, 31 October 2025
Health Biotech Limited, an Indian pharma company focused on research, participated successfully at CPHI Frankfurt 2025, a leading global pharmaceutical exhibition, held from October 28 to 30 in Germany.
"Shaping Pharma's Future" was the theme of the event, which attracted the experts and the innovators from the entire pharma value chain worldwide.
With a wide range of product offerings and advanced manufacturing capabilities, Health Biotech was the talk of the international delegates and business partners. The company's involvement in the event was a witness to its commitment to quality as well as leadership in pharmaceutical innovations.
On the occasion, Parmjit Arora, Managing Director of Health Biotech, said, "CPHI Frankfurt is the venue worldwide where we can initiate collaborations that matter. Our participation is our testament, to innovation, manufacturing research-led and, the accessibility of affordable, high-quality medicines at a global level."
Also Read: FUJIFILM India Launches FW500 Clinical Chemistry Analyzer
The company, with its facility that meets WHO-GMP and ISO 9001:2008 standards and located in the Baddi industrial area, is approximately producing 1,000 pharmaceutical products covering the major therapeutic areas of oncology, hormones, and critical care.
Its manufacturing skill can be seen in injectables, prefilled syringes, ointments, eye and nasal drops, and various advanced drug delivery systems.
After setting up in 2005, the company has turned into a reliable partner for big pharmaceutical brands like Cipla, Lupin, Piramal, and Cadila. Health Biotech's attendance at CPHI Frankfurt 2025 is a testament to its expansion across the globe and its relentless quest for scientific innovation, dependability, and pharmaceutical excellence of the highest standard.
.jpg)
